Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-26-001409
Accepted
2026-05-01 00:15:23
Documents
1
Effectiveness Date
2026-04-30

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 603
  Complete submission text file 9999999995-26-001409.txt   1788
Mailing Address 101 MAIN STREET SUITE 1220 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1220 CAMBRIDGE MA 02142 45 2138 7627
Hemab Therapeutics Holdings, Inc. (Filer) CIK: 0002114044 (see all company filings)

EIN.: 414241952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-294989 | Film No.: 26928620
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)